United States Multicenter Clinical Usage Study of the STAN 21 Electronic Fetal Monitoring System

Lawrence D Devoe, Michael Ross, Clayton Wilde, Maureen Beal, Andrej Lysikewicz, Jeffrey Maier, Victor Vines, Isis Amer-Wåhlin, Håkan Lilja, Håkan Norén, Dev Maulik

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Objective: The fetal electrocardiogram system for electronic fetal monitoring (EFM) (STAN S21, Neoventa Medical, Moelndal, Sweden) has led to improved perinatal outcomes in other countries. We aimed to assess the ability of United States (US) obstetricians to use this system appropriately for intrapartum care. Study design: A prospective nonrandomized trial was conducted in 6 sites. Enrollment required a singleton vertex fetus, >36 weeks' gestation, with indications for direct fetal monitoring during first stage of labor. Appropriate use was measured by negative predictive value (NPV) of nonintervention for fetuses with nonreassuring fetal heart rate (FHR) patterns, normal STAN readings, and normal neonatal outcomes with umbilical cord arterial pH >7.12; and percent agreement (PA) for intervention decisions with 3 STAN experts who conducted retrospective case reviews blinded to outcome. Results: Five hundred and thirty patients were enrolled. An NPV of 95.2% was achieved while PA between investigators and STAN experts was 84%, and 90%, for intervention and nonintervention, respectively. No fetus with metabolic acidosis requiring intervention was missed by US clinicians. Conclusion: US clinicians used the STAN system appropriately in a manner similar to that of experienced STAN users.

Original languageEnglish (US)
Pages (from-to)729-734
Number of pages6
JournalAmerican journal of obstetrics and gynecology
Volume195
Issue number3
DOIs
StatePublished - Sep 1 2006

Fingerprint

Cardiotocography
Fetus
Fetal Monitoring
First Labor Stage
Fetal Heart Rate
Umbilical Cord
Acidosis
Sweden
Reading
Electrocardiography
Research Personnel
Pregnancy
Clinical Studies

Keywords

  • Fetal electrocardiogram
  • Intrapartum fetal monitoring

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

United States Multicenter Clinical Usage Study of the STAN 21 Electronic Fetal Monitoring System. / Devoe, Lawrence D; Ross, Michael; Wilde, Clayton; Beal, Maureen; Lysikewicz, Andrej; Maier, Jeffrey; Vines, Victor; Amer-Wåhlin, Isis; Lilja, Håkan; Norén, Håkan; Maulik, Dev.

In: American journal of obstetrics and gynecology, Vol. 195, No. 3, 01.09.2006, p. 729-734.

Research output: Contribution to journalArticle

Devoe, LD, Ross, M, Wilde, C, Beal, M, Lysikewicz, A, Maier, J, Vines, V, Amer-Wåhlin, I, Lilja, H, Norén, H & Maulik, D 2006, 'United States Multicenter Clinical Usage Study of the STAN 21 Electronic Fetal Monitoring System', American journal of obstetrics and gynecology, vol. 195, no. 3, pp. 729-734. https://doi.org/10.1016/j.ajog.2006.06.002
Devoe, Lawrence D ; Ross, Michael ; Wilde, Clayton ; Beal, Maureen ; Lysikewicz, Andrej ; Maier, Jeffrey ; Vines, Victor ; Amer-Wåhlin, Isis ; Lilja, Håkan ; Norén, Håkan ; Maulik, Dev. / United States Multicenter Clinical Usage Study of the STAN 21 Electronic Fetal Monitoring System. In: American journal of obstetrics and gynecology. 2006 ; Vol. 195, No. 3. pp. 729-734.
@article{9da48d11ed6b4c5e96830ac69e611b20,
title = "United States Multicenter Clinical Usage Study of the STAN 21 Electronic Fetal Monitoring System",
abstract = "Objective: The fetal electrocardiogram system for electronic fetal monitoring (EFM) (STAN S21, Neoventa Medical, Moelndal, Sweden) has led to improved perinatal outcomes in other countries. We aimed to assess the ability of United States (US) obstetricians to use this system appropriately for intrapartum care. Study design: A prospective nonrandomized trial was conducted in 6 sites. Enrollment required a singleton vertex fetus, >36 weeks' gestation, with indications for direct fetal monitoring during first stage of labor. Appropriate use was measured by negative predictive value (NPV) of nonintervention for fetuses with nonreassuring fetal heart rate (FHR) patterns, normal STAN readings, and normal neonatal outcomes with umbilical cord arterial pH >7.12; and percent agreement (PA) for intervention decisions with 3 STAN experts who conducted retrospective case reviews blinded to outcome. Results: Five hundred and thirty patients were enrolled. An NPV of 95.2{\%} was achieved while PA between investigators and STAN experts was 84{\%}, and 90{\%}, for intervention and nonintervention, respectively. No fetus with metabolic acidosis requiring intervention was missed by US clinicians. Conclusion: US clinicians used the STAN system appropriately in a manner similar to that of experienced STAN users.",
keywords = "Fetal electrocardiogram, Intrapartum fetal monitoring",
author = "Devoe, {Lawrence D} and Michael Ross and Clayton Wilde and Maureen Beal and Andrej Lysikewicz and Jeffrey Maier and Victor Vines and Isis Amer-W{\aa}hlin and H{\aa}kan Lilja and H{\aa}kan Nor{\'e}n and Dev Maulik",
year = "2006",
month = "9",
day = "1",
doi = "10.1016/j.ajog.2006.06.002",
language = "English (US)",
volume = "195",
pages = "729--734",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - United States Multicenter Clinical Usage Study of the STAN 21 Electronic Fetal Monitoring System

AU - Devoe, Lawrence D

AU - Ross, Michael

AU - Wilde, Clayton

AU - Beal, Maureen

AU - Lysikewicz, Andrej

AU - Maier, Jeffrey

AU - Vines, Victor

AU - Amer-Wåhlin, Isis

AU - Lilja, Håkan

AU - Norén, Håkan

AU - Maulik, Dev

PY - 2006/9/1

Y1 - 2006/9/1

N2 - Objective: The fetal electrocardiogram system for electronic fetal monitoring (EFM) (STAN S21, Neoventa Medical, Moelndal, Sweden) has led to improved perinatal outcomes in other countries. We aimed to assess the ability of United States (US) obstetricians to use this system appropriately for intrapartum care. Study design: A prospective nonrandomized trial was conducted in 6 sites. Enrollment required a singleton vertex fetus, >36 weeks' gestation, with indications for direct fetal monitoring during first stage of labor. Appropriate use was measured by negative predictive value (NPV) of nonintervention for fetuses with nonreassuring fetal heart rate (FHR) patterns, normal STAN readings, and normal neonatal outcomes with umbilical cord arterial pH >7.12; and percent agreement (PA) for intervention decisions with 3 STAN experts who conducted retrospective case reviews blinded to outcome. Results: Five hundred and thirty patients were enrolled. An NPV of 95.2% was achieved while PA between investigators and STAN experts was 84%, and 90%, for intervention and nonintervention, respectively. No fetus with metabolic acidosis requiring intervention was missed by US clinicians. Conclusion: US clinicians used the STAN system appropriately in a manner similar to that of experienced STAN users.

AB - Objective: The fetal electrocardiogram system for electronic fetal monitoring (EFM) (STAN S21, Neoventa Medical, Moelndal, Sweden) has led to improved perinatal outcomes in other countries. We aimed to assess the ability of United States (US) obstetricians to use this system appropriately for intrapartum care. Study design: A prospective nonrandomized trial was conducted in 6 sites. Enrollment required a singleton vertex fetus, >36 weeks' gestation, with indications for direct fetal monitoring during first stage of labor. Appropriate use was measured by negative predictive value (NPV) of nonintervention for fetuses with nonreassuring fetal heart rate (FHR) patterns, normal STAN readings, and normal neonatal outcomes with umbilical cord arterial pH >7.12; and percent agreement (PA) for intervention decisions with 3 STAN experts who conducted retrospective case reviews blinded to outcome. Results: Five hundred and thirty patients were enrolled. An NPV of 95.2% was achieved while PA between investigators and STAN experts was 84%, and 90%, for intervention and nonintervention, respectively. No fetus with metabolic acidosis requiring intervention was missed by US clinicians. Conclusion: US clinicians used the STAN system appropriately in a manner similar to that of experienced STAN users.

KW - Fetal electrocardiogram

KW - Intrapartum fetal monitoring

UR - http://www.scopus.com/inward/record.url?scp=33748708908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748708908&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2006.06.002

DO - 10.1016/j.ajog.2006.06.002

M3 - Article

VL - 195

SP - 729

EP - 734

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 3

ER -